Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of pemetrexed in previously-treated advanced squamous cell lung carcinoma with low thymidylate synthase
KCT0003518Phase 2Completed
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in Pulmonary squamous cell carcinoma, sponsored by Samyang Biopharmaceuticals Corporation. Started Jul 2016; status: completed.
02
Drugs
pemetrexed
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on KCT0003518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003518.